Accendra Health (ACH) vs BioNexus Gene Lab (BGLC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Accendra Health is the larger company by market cap ($34.7 million vs $3.9 million), about 8.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ACH | BGLC |
|---|---|---|
| Share price | $0.4518 | $1.33 |
| Market cap | $34.75M | $3.89M |
| 1-day change | -4.46% | -1.56% |
| YTD return | -83.11% | — |
| 1-year return | -90.07% | — |
| 5-year return | -98.56% | — |
| Forward P/E | 4.95 | — |
| EPS (TTM) | $-1.44 | $-1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.60 | $5.89 |
| 52-week low | $0.44 | $1.07 |
| Distance from 52-week high | -91.93% | -77.48% |
| Average volume | 1.40M | 11.08K |
| Shares outstanding | 76.90M | 2.93M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Accendra Health is about 8.9 times larger than BioNexus Gene Lab by market value ($34.75M vs $3.89M).
ACH vs BGLC FAQ
Which is bigger, Accendra Health or BioNexus Gene Lab?
Accendra Health (ACH) is larger, with a market capitalization of $34.75M compared with $3.89M for BioNexus Gene Lab (BGLC).
Are Accendra Health and BioNexus Gene Lab in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.